Retentissement de l'ECMO post opératoire sur la fonction respiratoire et les complications bronchiques chez les patients transplantés pour hypertension pulmonaire
Year: 2023
Type: dissertation
Study design: Observational Study
Abstract: The use of ECMO is a common and necessary therapy in lung transplantation for pulmonary hypertension. It has led to a reduction in early mortality in this indication and may reduce primary graft dysfunction. The impact of this therapy on respiratory function remains poorly studied. In particular, forced expiratory volume in one second (FEV1) is associated with a decrease in survival in these patients when it is reduced in the first year. The main objective of this study is therefore to investigate the effect of postoperative ECMO on FEV values during the first year.We conducted a retrospective study of bipulmonary transplant patients between January 2015 and December 2019 for pulmonary hypertension. We sought to explore the association between the presence of postoperative ECMO and lung function, assessed by baseline and 1-year LFE values between patients with postoperative ECMO and those without postoperative assistance.During the study period, 106 patients were transplanted for PH. Of these, 47 patients (44%) received postoperative ECMO (38 VA ECMO and 9 VV ECMO). Baseline PFTs parameters were significantly decreased in the ECMO group: FEV1 89% vs. 75% (p<0.01), CV 96% vs. 84% (p=0.01). Multivariate analysis showed a decrease in baseline FEV1 when postoperative ECMO was present (p=0.01), and in older patients (p=0.02). Mortality in our cohort was lower than that reported in the literature in the indication of PH: 10% in the group without ECMO, 17% in the group with ECMO.In patients who received ECMO postoperatively in bipulmonary transplantation, the maximum FEV1 and CV achieved post-transplant were decreased. At one year, the decrease in FEV1 and CV persisted.
Source: HAL
Author: Ordi, Aloïs
Institution: Sorbonne Université
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7052498009
